Although our previous study including nine drug-naïve patients suggested that the monoamine oxidase B (MAOB) inhibitor rasagiline, which is capable of CDS, is effective for mild dysphagia in PD [12], investigations including mid- to late-stage PD patients are needed to reach to a conclusion. This evidence concerns the gene MAOB and Parkinson disease.